By Nicholas G. Miller
Shares of Perrigo slipped after the company posted second-quarter earnings and revenue below Wall Street's expectations.
The stock was down 13%, to $23.22, and is down 19% over the last 12 months.
The Irish over-the-counter health products company reported a loss of $8.4 million, or 6 cents a share, compared with a loss of $108.4 million, or 79 cents a share, a year prior.
Adjusted earnings were 57 cents a share. Wall Street expected 59 cents, according to FactSet.
The company reported $1.06 billion in revenue, a tick down from $1.07 billion the prior year. Analysts expected $1.08 billion. Top-line declines were fueled by a 1.9% fall in revenue from the company's Americas division. The company cited "a challenging consumer environment in the U.S. and the EU."
The company reaffirmed its full-year revenue guidance of flat to up 3%, but said it expected the lower end of that guidance, citing slower recovery in the company's infant-formula business and "challenging market consumption."
Write to Nicholas G. Miller at nicholas.miller@wsj.com
(END) Dow Jones Newswires
August 06, 2025 14:20 ET (18:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.